FCMI
Foresite Capital Management II Portfolio holdings
AUM
$29.2M
This Quarter Return
+50.84%
1 Year Return
+44.84%
3 Year Return
-66.21%
5 Year Return
-37.37%
10 Year Return
–
AUM
$607M
AUM Growth
+$607M
(+28%)
Cap. Flow
-$80.2M
Cap. Flow
% of AUM
-13.21%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
2
Closed
2
Top Buys
No buys this quarter
Top Sells
| 1 |
AIMT
Aimmune Therapeutics, Inc.
AIMT
|
$54.6M |
| 2 |
EPZM
Epizyme, Inc
EPZM
|
$22.1M |
| 3 |
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
|
$2.77M |
| 4 |
Insmed
INSM
|
$836K |
Sector Composition
| 1 | Healthcare | 93.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
10x Genomics
TXG
$1.74B
| $521M | 85.84% |
6,837,253
| – | – |
|
|
AERI
2
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $40.4M | 6.66% |
1,672,714
| – | – |
|
|
3
Insmed
INSM
$28.8B
| $21M | 3.46% |
880,016
-35,000
| -4% | -$836K |
|
|
EPZM
4
DELISTED
Epizyme, Inc
EPZM
| $14.5M | 2.4% |
591,304
-897,140
| -60% | -$22.1M |
|
|
XLRN
5
DELISTED
Acceleron Pharma Inc.
XLRN
| $10M | 1.65% |
188,602
| – | – |
|
|
AIMT
6
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| – | – |
-2,605,499
| Closed | -$54.6M |
|
|
ALDR
7
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| – | – |
-146,800
| Closed | -$2.77M |
|